PT -- GlaxoSmithKline has posted its fourth-quarter results which reveal a 33% fall in operating profit, excluding previously-announced legal charges of some £2.17 billion, to £2.13 billion, while group turnover was down 13% at constant exchange rates, to £7.20 billion.
